Complication | Cases identified in mortality review | Cases identified in administrative data | Cases identified in review and administrative data | κ |
---|---|---|---|---|
Selected healthcare associated infections | ||||
Clostridium difficile | 5 | 10 | 4 | 0.53 |
Sepsis | 89 | 169 | 48 | 0.29 |
CVC associated infection | 6 | 12 | 1 | 0.1 |
Surgical site infection | 20 | 11 | 3 | 0.18 |
Fungal infection | 5 | NA | ||
Urinary catheter associated infection | 7 | 0 | 0 | |
VRE bacteremia | 4 | 0 | 0 | |
MRSA infection | 7 | 12 | 4 | 0.42 |
ESBL producing bacteria | 15 | NA | ||
Ventilator associated pneumonia | 42 | 23 | 11 | 0.32 |
Selected healthcare associated complications | ||||
Venous thromboembolism | 9 | 40 | 3 | 0.11 |
Adverse drug event | 5 | NA | ||
Fall-related injury | 2 | 5 | 1 | 0.28 |
Technical surgical complication | 8 | 50 | 3 | 0.09 |
Other complications | ||||
Anesthesia-related complication | 2 | 1 | 0 | −0.0013 |
Non-surgical related complication | 3 | NA | ||
Equipment or device malfunction | 0 | NA | ||
Equipment or device misuse (human error) | 1 | NA | ||
Interventional radiology complication | 1 | NA | ||
Pressure ulcers | 1 | 14 | 0 | −0.0018 |
Bedside procedure | 2 | NA |
CVC, Central Venous Catheter; ESBL; Extended-spectrum beta-lactamase; MRSA, Methicillin-resistant Staphylococcus aureus; VRE, Vancomycin-resistant Enterococcus.